ursodeoxycholic acid has been researched along with Chronic Hepatitis C in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (17.07) | 18.2507 |
| 2000's | 25 (60.98) | 29.6817 |
| 2010's | 9 (21.95) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carreño, V | 1 |
| Boldizhar, P; Derbak, M | 1 |
| Matsumura, H; Matsuoka, S; Moriyama, M; Nakamura, H; Nirei, K | 1 |
| Alves, K; Badri, PS; Ding, B; Dutta, S; Menon, RM; Redman, R; Rodrigues, L; Uchiyama, N; Zha, J | 1 |
| Kurmanova, GM; Kurmanova, KB; Sadykova, ShS | 1 |
| Chino, O; Hanashi, T; Kikuchi, M; Kondoh, Y; Makuuchi, H; Nakamura, T; Ogawa, T; Sadahiro, S; Tajima, T; Tanaka, Y; Yokoyama, D | 1 |
| Aslan, V; Naz, H | 1 |
| Fukumoto, M; Ido, A; Moriuchi, A; Nishida, C; Nosaki, T; Oketani, M; Oku, M; Sogabe, A; Tokunaga, K; Tsubouchi, H; Uto, H | 1 |
| Ikegami, T; Matsuzaki, Y; Saito, Y | 1 |
| Ando, M; Anzai, T; Asagi, A; Hirohata, M; Miyake, Y; Miyatake, H; Moriya, A; Nakatsu, M; Yasuhara, H | 1 |
| Gonciarz, Z; Jurzak, M; Machniak, M; Mazur, W; Mazurek, U; Wilczok, T | 1 |
| Inada, M; Maeda, H; Matsuda, Y; Matsuyama, T | 1 |
| Bernard, B; Cadranel, JF; Di Martino, V; Dorent, R; Gandjbakhch, I; Ghoussoub, JJ; Grippon, P; Hoang, C; Huraux, JM; Lunel, F; Myara, A; Opolon, P; Pauwels, A; Perrin, M; Thabut, D; Trivin, F | 1 |
| Chen, W; Gluud, C; Liu, J | 2 |
| Hayashi, H; Iino, S; Ikoma, J; Kaito, M; Kajiwara, E; Kakumu, S; Kato, J; Kawamura, K; Kimura, F; Kobayashi, Y; Kohgo, Y; Niitsu, Y; Ogata, K; Okanoue, T; Saito, H; Sata, M; Sumida, Y; Wakusawa, S; Yano, M; Yoshioka, K; Yotsuyanagi, H | 1 |
| Yamada, G | 1 |
| Attia, M; Badran, HM; Barakat, E; El-Nakeeb, A; El-Tawil, A; El-Zayadi, AR; Saied, A; Selim, O; Zalata, K | 1 |
| Ahmed, WU; Alam, SE; Mehdi, I; Qureshi, H | 1 |
| Rockey, DC | 1 |
| Brok, J; Gluud, C; Gong, Y; Koretz, RL | 1 |
| Hayashi, N; Iino, S; Kumada, H; Makino, I; Nishiguchi, S; Okita, K; Omata, M; Tanikawa, K; Toda, G; Tomita, E; Toyota, J; Yoshida, H | 1 |
| Poupon, R; Serfaty, L | 1 |
| Shiraki, K; Takei, Y | 1 |
| Borozan, I; Chen, L; Coltescu, C; Edwards, AM; Guindi, M; Heathcote, EJ; McGilvray, ID; Meng, X; Milkiewicz, P; Ostrowski, MA; Sun, J | 1 |
| Abdelmalek, MF; Gossard, AA; Gross, JB; Harrison, ME; Lindor, KD; Poterucha, JJ; Rakela, J; Spivey, JR | 1 |
| Makino, I; Nakamura, K | 1 |
| Perrillo, RP; Younossi, ZM | 1 |
| Aoshima, M; Aso, K; Makino, I; Matui, T; Nakade, Y; Nakamura, K; Sato, Y; Takamoto, S; Tamori, K; Yokohama, S; Yoneda, M | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Kobayashi, M; Kumada, H; Murashima, N; Saitoh, S; Suzuki, Y; Tsubota, A | 1 |
| Beccarello, A; Bortolato, L; Ceselli, S; Crepaldi, G; Crovatto, M; Lirussi, F; Morselli-Labate, AM; Santini, G | 1 |
| Harada, H; Kamitsukasa, H; Kojima, H; Murai, S; Tokita, H; Yagura, M | 1 |
| Harada, M; Kawaguchi, T; Koga, H; Ohishi, M; Sakisaka, S; Sasatomi, K; Sata, M; Taniguchi, E; Tanikawa, K; Uchimura, Y; Ueno, T | 1 |
| Accogli, E; Azzaroli, F; Fabbri, C; Festi, D; Fusaroli, P; Jaboli, MF; Marchetto, S; Mazzella, G; Mazzeo, C; Montagnani, M; Pezzoli, A; Roda, E | 1 |
| Kasahara, A | 1 |
| Beuers, U; Bonnand, AM; Capron, JP; Chrétien, Y; Grangé, JD; Guéchot, J; Larrey, D; Mathiex-Fortunet, H; Paumgartner, G; Poupon, R; Poupon, RE; Queneau, PE; Raabe, JJ; Serfaty, L; St Marc Girardin, MF; Thieffin, G; Trépo, C; Vetter, D; Zafrani, ES | 1 |
| Kakisaka, Y; Mitsuyoshi, H; Nakashima, T; Sumida, Y; Yoh, T | 1 |
| Blendis, LM; Brill, S; Halpern, Z; Ibrahim, A; Katz, GG; Konikoff, FM; Magazinik, S; Malkiewicz, IM; Neuman, MG; Peretz, H; Sapir, D; Shear, NH | 1 |
| Shiffman, ML | 1 |
| Alvarez, V; Castellano, G; Colina, F; Gonzalez, C; Muñoz-Yague, T; Paz, E; Rodriguez, S; Sánchez-Pobre, P; Solís-Herruzo, J; Yela, C | 1 |
12 review(s) available for ursodeoxycholic acid and Chronic Hepatitis C
| Article | Year |
|---|---|
Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy.
Topics: Animals; Antiviral Agents; Biological Products; Contraindications; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Iron; Ursodeoxycholic Acid | 2014 |
Bile acids for viral hepatitis.
Topics: Antiviral Agents; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Randomized Controlled Trials as Topic; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2003 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
New therapies in hepatitis C virus and chronic liver disease: antifibrotics.
Topics: Colchicine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-gamma; Interleukin-10; Liver Cirrhosis; Phosphatidylcholines; Silymarin; Ursodeoxycholic Acid | 2006 |
Hepatology may have problems with putative surrogate outcome measures.
Topics: Antiviral Agents; Bilirubin; Biomarkers; Cholagogues and Choleretics; Gastroenterology; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis, Biliary; Liver Diseases; Outcome Assessment, Health Care; Reproducibility of Results; Ribavirin; Ursodeoxycholic Acid; Viral Load | 2007 |
Bile acids for viral hepatitis.
Topics: Antiviral Agents; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Randomized Controlled Trials as Topic; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2007 |
Ursodeoxycholic acid in chronic hepatitis C.
Topics: Apoptosis; Cholagogues and Choleretics; Disease Progression; Hepatitis C, Chronic; Humans; Liver Neoplasms; Ursodeoxycholic Acid | 2007 |
[General therapy of type C chronic hepatitis: efficacy and limitation of hepatoprotective agents].
Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Glycyrrhetinic Acid; Hepatitis C, Chronic; Humans; Ursodeoxycholic Acid | 2008 |
[Autoimmune hepatitis: progress in its treatment].
Topics: Azathioprine; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Middle Aged; Prednisolone; Ursodeoxycholic Acid | 1999 |
The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C.
Topics: Amantadine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cholagogues and Choleretics; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Rimantadine; RNA, Viral; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
Treatment strategies for chronic hepatitis C virus infection.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Iron Overload; Liver Neoplasms; Ribavirin; Treatment Outcome; Ursodeoxycholic Acid | 2000 |
Management of interferon therapy nonresponders.
Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Interleukin-10; Ribavirin; RNA, Viral; Ursodeoxycholic Acid | 2001 |
14 trial(s) available for ursodeoxycholic acid and Chronic Hepatitis C
| Article | Year |
|---|---|
[Correction of dyslipidemia in patients with chronic hepatitis C, combined with diabetes type 2].
Topics: Antiviral Agents; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Hepatitis C, Chronic; Humans; Male; Middle Aged; S-Adenosylmethionine; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Incidence of hepatocellular carcinoma reduced by phlebotomy treatment in patients with chronic hepatitis C.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Phlebotomy; Platelet Count; Ursodeoxycholic Acid | 2015 |
Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Arylsulfonates; Cholagogues and Choleretics; Cytokines; D-Alanine Transaminase; Drug Resistance; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Safety; Sulfonium Compounds; Th2 Cells; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Bile Acids and Salts; Cholagogues and Choleretics; Chronic Disease; Double-Blind Method; Female; gamma-Glutamyltransferase; Heart Transplantation; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Liver; Male; Middle Aged; Placebos; Ursodeoxycholic Acid | 2003 |
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
Topics: Adult; Alanine Transaminase; Cholagogues and Choleretics; Female; Hepatitis C, Chronic; Humans; Iron Overload; Male; Middle Aged; Phlebotomy; Prospective Studies; Ursodeoxycholic Acid | 2004 |
Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Necrosis; Protective Agents; Ribavirin; RNA, Viral; Silymarin; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Bile Acids and Salts; Biomarkers; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid; Viral Load | 2007 |
Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial.
Topics: Adult; Antiviral Agents; Biopsy; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Recombinant Proteins; RNA, Viral; Transaminases; Treatment Outcome; Ursodeoxycholic Acid | 1998 |
Effect of ursodeoxycholic acid on autoimmune-associated chronic hepatitis C.
Topics: Alanine Transaminase; Biomarkers; Female; Fluorescent Antibody Technique, Indirect; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Liver Function Tests; Male; Middle Aged; Prospective Studies; Time Factors; Ursodeoxycholic Acid | 1999 |
Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.
Topics: Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Cholagogues and Choleretics; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Time Factors; Treatment Outcome; Ursodeoxycholic Acid; Viremia | 1999 |
Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholagogues and Choleretics; Female; gamma-Glutamyltransferase; Genotype; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
Efficacy of ursodeoxycholic acid in association with alpha-interferon for chronic hepatitis C in alpha-interferon non-responder patients.
Topics: Analysis of Variance; Antiviral Agents; Chi-Square Distribution; Cholagogues and Choleretics; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Ursodeoxycholic Acid | 2000 |
Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon.
Topics: Adult; Aged; Antiviral Agents; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Male; Middle Aged; Reference Values; Statistics, Nonparametric; Treatment Outcome; Ursodeoxycholic Acid | 2000 |
Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate.
Topics: Adult; Cytokines; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Ursodeoxycholic Acid | 2001 |
15 other study(ies) available for ursodeoxycholic acid and Chronic Hepatitis C
| Article | Year |
|---|---|
Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects.
Topics: Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Japan; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Proline; Ritonavir; Sulfonamides; Ursodeoxycholic Acid; Valine; Young Adult | 2015 |
[EFFECTS OF URSODEOXYCHOLIC ACID IN STANDART INTERFERONTHERAPY OF PATIENTS WITH CHRONIC HEPATITIS C AND B].
Topics: Adult; Alkaline Phosphatase; Bilirubin; Female; gamma-Glutamyltransferase; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid | 2015 |
A Surgical Case of Primary Splenic Malignant Lymphoma Complicating Chronic Hepatitis C.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diffusion Magnetic Resonance Imaging; Doxorubicin; Hepatitis C, Chronic; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Radionuclide Imaging; Rituximab; Splenectomy; Splenic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ursodeoxycholic Acid; Vincristine | 2016 |
Treatment of autoimmune thrombocytopenia in a case of chronic hepatitis C with ursodeoxycholic acid.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Ribavirin; Treatment Outcome; Ursodeoxycholic Acid | 2009 |
Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C.
Topics: Aged; Alanine Transaminase; Cholagogues and Choleretics; Female; Follow-Up Studies; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Count; Renal Dialysis; Retrospective Studies; Thrombocytopenia; Time Factors; Ursodeoxycholic Acid | 2010 |
[Alternative therapies for hepatitis C: UDCA and SNMC].
Topics: Cysteine; Drug Combinations; Glycine; Glycyrrhetinic Acid; Hepatitis C, Chronic; Humans; Liver; Ursodeoxycholic Acid | 2011 |
Long-term combined therapy with very-low-dose peginterferon and ursodeoxycholic acid decreased the spleen size in a patient with hepatitis C virus-related cirrhosis.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Spleen; Ursodeoxycholic Acid | 2013 |
Interferon versus interferon and UDCA combined therapy in chronic hepatitis C.
Topics: DNA, Complementary; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Polymerase Chain Reaction; RNA; RNA, Viral; Time Factors; Ursodeoxycholic Acid | 2001 |
Role of ursodeoxycholic acid in lowering ALT in chronic liver disease.
Topics: Administration, Oral; Adult; Alanine Transaminase; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid | 2006 |
Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
Topics: Cholagogues and Choleretics; Down-Regulation; Female; Gene Expression; Gene Expression Profiling; Hepatitis B; Hepatitis C, Chronic; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Ursodeoxycholic Acid | 2008 |
Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepatitis C; Hepatitis C, Chronic; Humans; Injections, Intramuscular; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Procollagen; Retrospective Studies; RNA, Viral; Ursodeoxycholic Acid | 2000 |
Ursodeoxycholic acid reduces expression of heat shock proteins in primary biliary cirrhosis.
Topics: Adult; Aged; Bile Ducts, Intrahepatic; Cell Count; Cholagogues and Choleretics; Cholangitis, Sclerosing; Epithelial Cells; Female; Fluorescent Antibody Technique, Indirect; Hepatitis C, Chronic; HSP70 Heat-Shock Proteins; Humans; Immunoblotting; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Ubiquitins; Ursodeoxycholic Acid | 2000 |
[Chronic hepatitis and cholangitis. The liver at risk].
Topics: Antiviral Agents; Cholangitis; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Ursodeoxycholic Acid | 1999 |
Differences in the efficacy of ursodeoxycholic acid and bile acid metabolism between viral liver diseases and primary biliary cirrhosis.
Topics: Adult; Aged; Aspartate Aminotransferases; Bile Acids and Salts; Cholic Acids; Female; gamma-Glutamyltransferase; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid | 2001 |
Chronic hepatitis C and autoimmune cholangitis: a case study and literature review.
Topics: Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Female; Hepatitis C, Chronic; Humans; Liver; Middle Aged; Mitochondria, Liver; Ursodeoxycholic Acid | 2002 |